<SEC-DOCUMENT>0001213900-16-019386.txt : 20170418
<SEC-HEADER>0001213900-16-019386.hdr.sgml : 20170418
<ACCEPTANCE-DATETIME>20161213171517
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-16-019386
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20161213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1213

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
		BUSINESS PHONE:		972-8-9396577

	MAIL ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-align: center; text-indent: 0.5in">December 13, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><U>VIA EDGAR</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>THERAPIX BIOSCIENCES LTD.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Registration Statement on Form F-1 (Registration No. 333-214458) -</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 96px">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Concurrence in Acceleration Request</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">H.C. Wainwright &amp; Co.,
LLC (&ldquo;<U>Wainwright</U>&rdquo;), as representative of the underwriters for the referenced offering, hereby concurs in the
request by Therapix Biosciences Ltd. that the effective date of the above-referenced registration statement be accelerated to 5:00
p.m. (Eastern Time), or as soon as practicable thereafter, on December 15, 2016, pursuant to Rule 461 under the Securities Act.
Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">H.C. WAINWRIGHT &amp; CO., LLC</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 36%">/s/ Mark W. Viklund</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Name: Mark W. Viklund<BR>Title: Chief Executive
Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  . .(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#CK:U@U5(+
M:T@,%XB,7=G)2;GD_P"R0"/KCCG /:?"J2R/CJWCLX'7R[2823.V3,=PP<=%
M&,<?J:YR72[Q]/M[.)+2(H1OD5CF7/*[OE['/7/;TKM?AQ#*_C*WEDB@22.T
MD221#EYB<?,QP.>*].J_<9XM!?O$_0[_ ,8>3'<>'II8BW_$T16V(6)7RY#C
M !)&0#CVJMXEN[6_N=!00W!;^U(QF:UDC!4ALC+*!@X''>I/&5ZEO>>']RE@
MFH"<CU58W&![Y<'\*/&]XMK_ &(S(6VZBLQ_W45L_CSQ7"NGS/2DU[WR-7Q-
MJ4NFZ*TENP6XGFBMHF/(5I'"!OPW9_"I3H>F_9RCP9<C'GDGSL_WO,^]GWS5
M35-.N/$%CJFG7!CMD65!:SQ.6=6 5U=@0.0V. >1QQ6?'XR$<YTN[L\ZHC&,
MB)OW#.,\AC\P!_W3CWJ4G;3<INSU->?1VO/#;:1=W4DC-$8_M)X?=_"_'\0X
M/UKC+R4MHVBZNL44=T=VD7T;  +(W[K<1_LN@]]I-=Q'+J45Q903K;.'@=[E
MT9@5D&W 08Y7DCD@]*YRX\-+J'B#6K&251875NMTL87F.>56C+CZ",GZN:<7
M;<F:NM/0UET^!]:L+2./]UI=N7R>3N;Y4!/?A7)]]IK+L=49?%L%X;P26FLQ
MM#%&'#+$8\M$?;>A=OJ0*B>^GL/!%O>7Q\V[U5XC<O"=O$@ .WT(C7 ]ZO>+
MK&TM/#,MW:VL$5S:/%/;ND87:ZN"O3MU!]B::WM\OZ^8/:ZZ:DNLPQMXT\-L
MZ@D_:-W'!P@(SZX/(]*IZI<WFB>)[O4[-&ET^.VA?4+5!R06D!F4?WE"C([K
M[@5!?:Y!=^)_#$PBD"LDCL#C(\P"-<?CU]ORK6MM4C/CC4+'8VY;.%=W&,J7
M8_I(OY&C6VW3]06K=N_Z"RQV%]XBL+N-8YH[G3[@[UY61=T.#[\,1]":YB2$
M:=X?FRI-YX8O?,Y/S36X;>,GOF-_^^EK?T[0GT?Q:!;2I_9DEM.\-MC_ %$C
M/$7"_P"P2,X]2:75M):;Q=9R*R"UN[=A>Q,,^;Y+!H_U8@Y[<4)ZV%):7MJ1
MQZ?;SZ;HNG%8W\^3[;.5[ '>VWV+LB8_NL163*-(AU?Q5#> (_VB%;4KE9%=
MX(R!&P^Z2Y[$<FMSP?ITUA:W"SR+)]FD-G;D9^6WC)V Y_B^;!^@]*S=-6UU
MS7_%NEW4),5U*N?HL:1_GE<BFGJ_ZZB>J6FK_P BQXFAN%^'D2:BXDOHDMO-
MD7O)O17(^N6_ U?:0ZAXJDTDG%C8VD<SPKP)7=F"@^JJ$/'0EN>@KG-9U2X_
MX0VXTN^/GW]M=PVCSJ2%E*NKASW!*KR.>?45LZA(UK=0^+K, V[V2K=V\APS
MQ9W*RD9&]2QX/!#=1@4K:?>5>[NO*_XEN]L]-L-2TZ6&X&G3R3[1'$"B77!^
M1E'#'N#U&/3-499K>S^(UQ)(DN6TN-AY4+R?,97!.%!P<!1FG6UZGC&?3+JS
M#0VEE=&X?SA\[L$90H R,?/G.>W2DBO$/Q/N8PA_X\8K?_@09Y,_3##\10D^
MO8&UHUM<+>6"Z^([S112J5TO<3)"T?/F8SA@,G'&?3BJVL>'=*LK_P .6\-M
MA9+[RI,N<R*()#\W//(!JR;Q/^%F^44;)T\P;L_Q;A)^6#^?:E\5WT=OKOAV
M,HQ*7IF/IC8R8'OEP?PIJ]U;M_F)VL[]_P!30N+*VTG1[NVTXM:RWA98?+;)
M$K+M!7<>V,_@35#2-5TZWL+G4KF*2QNK51#J-LNYUA<#.\JN<@@YW]QU/'&G
MX@L+J\L(9-/ECCO;687,!FSL) (*MCG!5F'XUQPN)O&TQNM*@BL+^*/R+B29
M]RSQD$F%@%^9#_>X*]0*E*Z')V=ON.JUO4)#<Z1IL,DD1U&=E>1<JZQI&SMC
MN"<!<]1D]#4U[H5G<6<L5HHL;G:?*N8!LD1NQR.3[@]>]99=_%VE6>JV&+6^
ML+LO$LIRA=05="1SL8$C.,]#CM1!XQ&J'[)IMJ5OY,H#<-B)#C.<C)./3 SZ
MBBSZ#NF]>NQ?@E75]<U"WN!NM[$QQ+">5=V0.68=#PR@ ]""?I5OX5\/:OIE
MUIV(K2ZN5M+FT3B,[P=KJO16#  XZ@\]!1JQE\-ZI<Z^F);*=$2\ASAPR\+(
MG8G!P0<=!SQ5BVG3Q.;2^A#1V5I,9 K_ 'WE4$#(Y&T;L]<DXZ8Y/R'^9T-%
;<U'JWB%XD8V&EY*@G%U)_P#&Z*7*Q>UB?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
